Alexandria Pharmaceuticals (AXPH)

Currency in EGP
800.21
-6.15(-0.76%)
Closed·
High dividend Yield
AXPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
795.02813.89
52 wk Range
386.011,000.96
Key Statistics
Bid/Ask
800.10 / 803.89
Prev. Close
806.36
Open
801
Day's Range
795.02-813.89
52 wk Range
386.01-1,000.96
Volume
695
Average Volume (3m)
1.67K
1-Year Change
102.8467%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AXPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Alexandria Pharmaceuticals Company Profile

Alexandria Co. For Pharmaceuticals & Chemical Industries operates as a pharmaceutical company in Egypt. The company manufactures, markets, and distributes branded generics of human and animal health products. It also provides human products, such as tablets, syrups, suppositories, drops, ampoule, and crème; medical appliances; and Veterinary Products. In addition, the company offers antibiotics and anesthetics, ophthalmic, cardiovascular, gastrointestinal, genitourinary, and respiratory drugs. Alexandria Co. For Pharmaceuticals & Chemical Industries was founded in 1962 and is based in Alexandria, Egypt.

Market
Egypt

Compare AXPH to Peers and Sector

Metrics to compare
AXPH
Peers
Sector
Relationship
P/E Ratio
10.2x12.8x−0.5x
PEG Ratio
0.130.240.00
Price/Book
4.0x3.2x2.6x
Price / LTM Sales
1.5x1.7x3.3x
Upside (Analyst Target)
-16.6%45.7%
Fair Value Upside
Unlock9.5%6.5%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 78.23%
Dividend Yield
7.87%
Industry Median 2.96%
Annualized payout
62.95
Paid annually
5-Years Growth
+32.35%
Growth Streak

Earnings

Latest Release
Sep 03, 2025
EPS / Forecast
13.55 / --
Revenue / Forecast
528.72M / --
EPS Revisions
Last 90 days

AXPH Income Statement

People Also Watch

FAQ

What Is the Alexandria Pharma (AXPH) Stock Price Today?

The Alexandria Pharma stock price today is 800.21

What Stock Exchange Does Alexandria Pharma Trade On?

Alexandria Pharma is listed and trades on the Egypt Stock Exchange.

What Is the Stock Symbol for Alexandria Pharma?

The stock symbol for Alexandria Pharma is "AXPH."

Does Alexandria Pharma Pay Dividends? What’s The Current Dividend Yield?

The Alexandria Pharma dividend yield is 7.87%.

What Is the Alexandria Pharma Market Cap?

As of today, Alexandria Pharma market cap is 4.00B.

What Is Alexandria Pharma's Earnings Per Share (TTM)?

The Alexandria Pharma EPS (TTM) is 78.23.

When Is the Next Alexandria Pharma Earnings Date?

Alexandria Pharma will release its next earnings report on Aug 28, 2025.

From a Technical Analysis Perspective, Is AXPH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Alexandria Pharma Stock Split?

Alexandria Pharma has split 3 times.

What is the current trading status of Alexandria Pharma (AXPH)?

As of Feb 07, 2026, Alexandria Pharma (AXPH) is trading at a price of 800.21, with a previous close of 806.36. The stock has fluctuated within a day range of 795.02 to 813.89, while its 52-week range spans from 386.01 to 1,000.96.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.